>800
Experimental tests across multiple CAR architectures
0.08%
Detection sensitivity for CAR-positive cells
Ultra-low
Nonspecific background signal
Reproducible
Performance across independent batches
The SCOPE BCMA CAR Detection Reagent enables precise identification and quantification of BCMA-directed CAR-expressing cells using flow cytometry.
Site-specific enzymatic labeling supports highly consistent reagent performance across production batches. Validated across BCMA CAR designs incorporating CD8α and IgG-derived hinge regions, enabling reliable detection across commonly used construct formats.
Designed for robust discrimination between CAR-positive and CAR-negative cells with minimal nonspecific binding.
Manufacturing processes optimized for consistent performance across independently produced reagent lots.
Compatible with standard flow cytometry staining protocols and standard instrument configurations.
Validated across BCMA CAR architectures incorporating CD8α and IgG-derived hinge regions.
Serial dilution experiments demonstrate reliable detection of rare CAR-positive populations down to 0.08%, with strong agreement between expected and measured values.

Detection of CAR-positive cells across serial dilution with consistent quantification at low frequencies.
The engineered antigen-based design minimizes nonspecific interactions, enabling clear separation between CAR-positive and CAR-negative populations with near-zero background signal.
Independent reagent batches demonstrate highly consistent signal intensity and CAR-positive frequencies, supporting reliable quantitative analysis across experiments.
Target
BCMA-directed CAR constructs
Application
Flow cytometry
Formats
PE, Biotin
Kit Size
30 tests
Use
Research use only
Research Use Only (RUO): This product is intended for research use only and is not for use in diagnostic or therapeutic procedures.